These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 21666337

  • 1. Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy.
    Mandal S, Sinha S, Abbas Z, Venkatesh P.
    Indian J Ophthalmol; 2011; 59(4):338-9. PubMed ID: 21666337
    [No Abstract] [Full Text] [Related]

  • 2. Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane.
    Shanmugam MP, Mythri HM, Shetty NS.
    Indian J Ophthalmol; 2007; 55(6):490-1. PubMed ID: 17951923
    [No Abstract] [Full Text] [Related]

  • 3. Optical coherence tomographic angiography of choroidal neovascularization associated with central serous chorioretinopathy.
    McClintic SM, Jia Y, Huang D, Bailey ST.
    JAMA Ophthalmol; 2015 Oct; 133(10):1212-4. PubMed ID: 26135638
    [No Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab for the treatment of feeder vessel of subfoveal choroidal neovascularization.
    Theodossiadis PG, Grigoropoulos VG, Emfietzoglou I, Vergados J, Chalkiadakis J, Theodossiadis GP.
    Eur J Ophthalmol; 2007 Oct; 17(5):853-6. PubMed ID: 17932868
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy.
    Pikkel J, Rumelt S.
    Eur J Ophthalmol; 2012 Oct; 22(3):488-91. PubMed ID: 21928270
    [Abstract] [Full Text] [Related]

  • 6. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA, Pan-American Collaborative Retina Study Group.
    Retina; 2008 Oct; 28(10):1387-94. PubMed ID: 18827735
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks.
    Sachdev N, Vishwanathan K, Gupta V, Singh R, Gupta A.
    Indian J Ophthalmol; 2007 Jun; 55(6):457-8. PubMed ID: 17951904
    [Abstract] [Full Text] [Related]

  • 10. Choroidal neovascularization in a patient with blunt trauma-caused traumatic retinopathy without choroidal rupture.
    Takahashi M, Kinoshita S, Saito W, Kase M, Ishida S.
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):137-40. PubMed ID: 20714747
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.
    Ben Yahia S, Herbort CP, Jenzeri S, Hmidi K, Attia S, Messaoud R, Khairallah M.
    Int Ophthalmol; 2008 Aug; 28(4):311-6. PubMed ID: 18401552
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.
    Shah NJ, Shah UN.
    Indian J Ophthalmol; 2011 Aug; 59(4):318-9. PubMed ID: 21666322
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy.
    Montero JA, Ruiz-Moreno JM, Fernandez-Muñoz M.
    Eur J Ophthalmol; 2011 Aug; 21(4):503-5. PubMed ID: 21279982
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.
    Broadhead GK, Chang A.
    Graefes Arch Clin Exp Ophthalmol; 2015 Jun; 253(6):979-81. PubMed ID: 25547617
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.
    Konstantinidis L, Mantel I, Zografos L, Ambresin A.
    Eur J Ophthalmol; 2010 Jun; 20(5):955-8. PubMed ID: 20306440
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab.
    Malik A, Sood S, Narang S.
    Int Ophthalmol; 2010 Aug; 30(4):425-8. PubMed ID: 20049508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.